Isoprenoids and Cancer
1. Global understanding of isoprenoids, their metabolism, and interface with disease.
2. Relate the clinical activity to underlying mechanisms of action(s) at the cellular and biochemical levels.
3. Know the relatively unique clinical pharmacology features associated with these agents.
4. Understand opportunities for new applications of these agents.
Presentation: 62 minutes
Recommended CitationHohl, MD, PhD, Raymond J., "Isoprenoids and Cancer" (2014). Kimmel Cancer Center, Presentations and Grand Rounds. Paper 14.